Author:
Feng Xin,Zidan Ahmed,Kamal Nahid S.,Xu Xiaoming,Sun Dajun,Walenga Ross,Boyce Heather,Cruz Celia N.,Ashraf Muhammad
Publisher
Springer Science and Business Media LLC
Subject
Drug Discovery,Pharmaceutical Science,Agronomy and Crop Science,Ecology,Aquatic Science,General Medicine,Ecology, Evolution, Behavior and Systematics
Reference43 articles.
1. Alexander L, Mannion RO, Weingarten B, Fanelli RJ, Stiles GL.
Development and impact of prescription opioid abuse deterrent formulation
technologies. Drug Alcohol Depend. 2014;138:1–6.
2. FDA US. Food and Drug Administration. Guidance for industry:
abuse-deterrent opioids — evaluation and labeling. 2015 [Available from: https://www.fda.gov/downloads/Drugs/Guidances/UCM334743.pdf. Accessed 04/05/2019.
3. Maincent J, Zhang F. Recent advances in abuse-deterrent
technologies for the delivery of opioids. Int J Pharm.
2016;510(1):57–72.
4. Rahman Z, Yang Y, Korang-Yeboah M, Siddiqui A, Xu X, Ashraf M, et
al. Assessing impact of formulation and process variables on in-vitro
performance of directly compressed abuse deterrent formulations. Int J Pharm.
2016;502(1):138–50.
5. Xu X, Gupta A, Al-Ghabeish M, Calderon SN, Khan MA. Risk based in
vitro performance assessment of extended release abuse deterrent formulations.
Int J Pharm. 2016;500(1–2):255–67.
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献